baber/WOPTO huggingface dataset:
Patent NZ-524923-A (NZ)
Title: Feed for ruminant neonates breeding and a regime
Inventor: LIS ALEJANDRO FABIAN
IPC: A23K1/18
Filed: 2003-03-25
Abstract: Feed for bovine neonates breeding producing a metabolic energy of 4200 calories and a process comprising a particular administration sequence for using such feed is disclosed, wherein the feed comprises a milk liquid diet part and a solid diet part, with the following components: 90 to 92% of dry matter, which comprised 25 to 26% of protein, 8 to 9% of fat, 3 to 3.5% of fiber, 6 to 7% of ash, 1.1 to 1.6% of Ca and 1.1 to 1.6% of P, wherein the feeds digestibility reaches 93% providing a metabolizable energy of 4200 calories and further the feeds thermoprocess breaks 1-4 and 1-6 alpha and beta thermolalibe links and breaks down complex starches into simple starches such as monosaccharides, disaccharides and polysaccharides.
Patent NZ-528185-A (NZ)
Title: Tower oscillation monitoring device
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2002-03-14
Abstract: The present invention concerns a method of controlling a wind power installation having a control apparatus for operational management of the wind power installation, in which the acceleration of the pylon is detected. The invention further concerns a wind power installation comprising a pylon, a control apparatus for operational management of the wind power installation and a device for detecting the acceleration of the pylon. Therefore the object of the present invention is to develop a method and a wind power installation of the kind set forth in the opening part of this specification, in such a way as to implement reliable and efficient oscillation monitoring in order to open up the above-mentioned frequency range for operation of the wind power installation. A method of controlling a wind power installation comprising a pylon and a control apparatus for operational management of the wind power installation or parts thereof, wherein there are provided means with which oscillation of the pylon of the wind power installation is detected, wherein the means for detecting the pylon oscillation detect the oscillation travel and/or the absolute deflection of the pylon in the upper part of the pylon out of its rest position and the values ascertained by the means for detecting the pylon oscillation are processed in the control apparatus, more specifically in such a way that the operational management of the wind power installation or parts thereof is altered if the oscillation and/or the absolute deflection of the pylon exceeds a predeterminable first limit value.
Patent NZ-529324-A (NZ)
Title: Core-glycosylated HCV envelope proteins made in yeast cells
Inventor: DEPLA ERIK
IPC: C12N1/16
Filed: 2002-04-24
Abstract: Described are HCV envelope proteins or functional fragments thereof, which are the product of expression in eukaryotic cells. More particularly said HCV envelope proteins are characterized in that on average up to 80% of their N-glycosylation sites are core-glycosylated. Of these N-glycosylated sites more than 70 % are glycosylated with an oligomannose containing 8 to 10 mannoses. Furthermore, the ratio of the oligomannoses with structure Man(7)-GlcNAc(2) over the oligomannose with structure Man(8)-GlcNAc(2) is less than or equal to 0.45. Less than 10 % of the oligomannoses is terminated with an alpha 1,3 linked mannose. These HCV envelope proteins are particularly suited for diagnostic, prophylactic and therapeutic purposes. A suitable eukaryotic cell for production of the HCV envelope proteins is a Hansenula yeast cell.
Patent NZ-531794-A (NZ)
Title: Sample mechanism with integrated liquid detection
Inventor: CROSS PETER STEPHEN
IPC: G01F23/24
Filed: 2004-03-25
Abstract: A sampler (1) for extracting sample volumes of substantially single-phase fluid or gas from a fluid-flow system containing multi-phase fluids (3) includes: a collection recess (4) adapted to separate substantially single-phase fluid from the multi-phase fluid (3); an extraction outlet (8) in the collection recess (4); at least one fluid sensor system (5) capable of sensing the presence and/or state of the single-phase fluid or gas in the collection recess (4); a fluid controller (6) capable of controlling fluid or gas flow from the collection recess (4) via the extraction outlet (8). The sampler is characterised in that either: a sample volume of the single-phase fluid or gas is obtainable by operating the fluid controller to allow the sample volume to flow through the extraction outlet after the fluid sensor has detected the presence of the minimum volume of single-phase fluid or gas in the fluid collection recess or the fluid sensor system (5) includes at least two distinct sensors respectively capable of utilizing distinct properties of the fluid or gas to determine the presence and/or state of the sample volume present in the collection recess (4).
Patent NZ-532467-A (NZ)
Title: Apparatus and method for detecting and correcting a corrupted broadcast time code
Inventor: NELSON DANIEL
IPC: H04H1/00
Filed: 2002-11-01
Abstract: An apparatus for processing audience measurement data is disclosed. The audience measurement data includes audience measurement data including a plurality of sequential data records, where each of the data records includes a time code retrieved from a broadcast signal and a read time. The read time corresponds to the time code such that a set of first intervals between the read times are mathematically related to a corresponding set of second intervals between the time codes, provided that the time codes are not corrupted. The apparatus comprises: (a) a data input port for receiving the plurality of data records; and (b) a processor coupled to the data input port. The processor is adapted to determine the magnitudes of the first and second intervals, wherein the processor is adapted to compare magnitudes of the first and second intervals to identify one or more of the time codes that are corrupted and to identify one or more of the time codes that are not corrupted. The processor is further adapted to calculate a corrected time code for each the time code that is corrupted.
Patent NZ-532555-A (NZ)
Title: Laser line level tool with magnetic mounting
Inventor: MARSHALL JAMES D
IPC: G01C15/00
Filed: 2004-04-26
Abstract: A laser line tool with level vials 16, 17, laser diode 12, line forming lens 13 and battery B together mounted on a frame 11 and within a case 22 which also mounts the control circuit 20, is provided with a magnet 24 attached to the base of the frame so that the tool can be mounted and attached to a magnetically attractive surface. In particular, a base unit 30 can be mounted by a spike 33 to a wall, and then the line tool can be easily attached and connected to the base by the attraction of the magnet onto the base.
Patent NZ-532703-A (NZ)
Title: A dental floss device
Inventor: DOUGAN MICHAEL
IPC: A61C15/04
Filed: 2002-11-22
Abstract: A dental floss device 1 comprises a handle 2 having a head piece 3 and a disposable holder 4 for a length of dental floss 5. The holder 4 comprises a base portion 20 and a pair of spaced-apart jaws 21 extending from the base and which extend to embrace the head piece 3 of the handle 2 when the holder 4 is in a correct alignment configuration with respect to the handle 2. The device has an interlock which ensures that the holder 4 can be interengaged with the head piece 3 only when the holder 4 is correctly aligned with the head piece 3. The interlock comprises a head interlock part provided by interlock grooves 10 and a holder interlock part provided by corresponding interlock tongues 11. There are two interlock grooves 10 and corresponding interlock tongues 11 which slidably interengage when the holder 4 is correctly aligned with the head piece 3. If the holder 4 is turned so that it is not correctly aligned with the head piece 3, the interlock tongues 11 of the holder 4 prevent engagement of the holder 4 with the head piece 3. Thus there is no risk that a user will incorrectly align and engage the dental floss holder with the head piece 3.
Patent NZ-533716-A (NZ)
Title: Vacuum cleaner housing for reduced complexity of construction
Inventor: BARKER DAVID
IPC: A47L9/22
Filed: 2004-06-23
Abstract: A vacuum cleaner 2 having a housing 4 having an inlet 12 and an outlet 54 is disclosed. Actuation of a motor 46 causes a fan to displace air out of outlet 54, and the resulting suction upstream of the fan draws dirty air through inlet 12 and inwardly through walls of filter unit 22. Air, from filter unit 22, passes along a duct to the motor 46 and fan. The housing 4 is formed from a first housing part defining a recess 36, and the recess is then closed by means of a closure member 56 to define the duct between the filter unit 22 and the motor 46.
Patent NZ-534624-A (NZ)
Title: Lithographic printing inks
Inventor: LATUNSKI MARK D
IPC: C09D11/02
Filed: 2002-08-02
Abstract: A lithographic ink composition, comprising a continuous phase comprising a hydrogen bonding vinyl polymer and an emulsified phase comprising water, wherein the vinyl polymer is other than a vinyl polymer comprising primary amide groups or amide groups having N-alkyl substituents of three or fewer carbon atoms. (62) Divided out of 530586
Patent NZ-535677-A (NZ)
Title: Intervertebral implant with detent
Inventor: MARNAY THIERRY
Filed: 1999-07-02
Abstract: Disclosed is an intervertebral implant as shown in figure 1 consisting of: an upper part having an upper surface for engaging a vertebra and having a bottom surface, a lower part having a lower surface for engaging a vertebra and an upper surface, an insert located between and engaging the bottom surface of the upper part and the upper surface of the lower part, the upper surface of the lower part being constructed to receive and fixedly secure said insert, the upper surface of the lower part comprising an elongated detent recess extending there across and having a step, and said insert having an elongated downward protrusion, parallel to the detent recess, which downward protrusion is resiliently engagable in the step of the detent recess as the insert is inserted onto the upper surface of the lower part. (62) Divided Out of 516410
Patent NZ-535775-A (NZ)
Title: System, method and computer program product for on-line travel and expense management
Inventor: SOMMERS MARK O
IPC: G06Q10/00
Filed: 2003-03-06
Abstract: A method in a computer system of arranging travel for large corporate and government organizations is disclosed. The method comprising: (a) receiving a customer login at an Internet web site and authenticating the customer; (b) receiving a selection of travel requirements from the customer; (c) making initial travel arrangements for the customer, based on the selection of travel requirements; (d) automatically generating a travel authorization form for the customer with the initial travel arrangements; (e) electronically forwarding the travel authorization form to an approver; (f) notifying the customer electronically when the approver has approved the travel authorization form; (g) notifying a travel agency of approval of the travel authorization form whereupon the travel agency performs reservation fulfilment; (h) automatically updating a financial system electronically prior to travel with data from the travel authorization form for the customer; (i) accepting expense data entered by the customer upon return from travel; and (j) automatically generating an electronic expense report from the customer expense data.
Patent NZ-538640-A (NZ)
Title: Probiotic bacterium: lactobacillus fermentum
Inventor: CONWAY PATRICIA LYNNE
IPC: A61K35/74
Filed: 2003-09-08
Abstract: Disclosed is a variant of the bacterium Lactobacillus fermentum and its use in treating gastrointestinal disorders, disorders of the mucosal surfaces or disturbances in the immune system or status of a subject.
Patent NZ-539944-A (NZ)
Title: Ruthenium complexes as (pre)catalysts for metathesis reactions
Inventor: GRELA KAROL
IPC: C01G55/00
Filed: 2003-10-10
Abstract: Disclosed are ruthenium carbene complexes of formula 1 wherein: L1 is a neutral ligand; X/X' are anionic ligands; R1 is alkyl or cycloalkyl; R2 is H, alkyl, alkenyl, alkinyl or aryl; R3 is alkyl, alkoxy or aryl, wherein aryl is optionally substituted with alkyl or alkoxy; n is 0, 1, 2 or 3. The complexes are used as catalysts for different types of metathesis reactions.
Patent NZ-541507-A (NZ)
Title: Hsp60 from arthrobacter
Inventor: GRIFFITHS STEVEN GARETH
IPC: A61K/
Filed: 2004-02-13
Abstract: Disclosed is the hsp60 gene from Anthrobacter. Also disclosed is the use of this gene in a vaccine composition and in treating an infectious disease.
Patent NZ-543104-A (NZ)
Title: Dispensing systems
Inventor: LIM BERNARD C B
IPC: A61M5/178
Filed: 2004-04-23
Abstract: A delivery system (10) for controlling the delivery of materials from dispensing devices, such as dispensing medications to patients, is disclosed. The system has dispensing means (12) with an outlet (20) for delivering one or more materials or articles; dispensing control means for controlling the passage of the material or article through the outlet; first identification means having first identity data to identify the dispensing means, or the material or article; second identification means (24) having second identification data associated with an entity, the entity being associated with the dispensing means; and permission control means to establish a predetermined condition of the dispensing control means when a predetermined relationship is established between the first identity data and second identity data. The first and second identification means can operate in recording or emitting modes.
Patent NZ-543419-A (NZ)
Title: Flavivirus replicon packaging system
Inventor: KHROMYKH ALEXANDER A
IPC: C12N7/04
Filed: 2004-06-07
Abstract: A tetracycline regulatable flaviviral packaging system is provided that facilitates expression of flaviviral structural proteins necessary for flaviviral RNA replicon packaging and virus like particle production in animal cells. This regulatable packaging system is compatible with Kunjin, Dengue and West Nile virus and other flaviviral replicon-based expression systems and produces unexpectedly high titres of virus-like particles. A particular application of this packaging system is the production of virus-like particles that package RNA comprising a flaviviral replicon and encoding a heterologous protein or peptide for expression in animal cells. Even more particularly, the packaging system is capable of delivering immunogens that induce a protective CD8 T cell-mediated immune response.
Patent NZ-545932-A (NZ)
Title: Anhydrous silver dihydrogen citrate compositions
Inventor: ARATA ANDREW B
IPC: A61K31/28
Filed: 2004-08-27
Abstract: Disclosed is an anhydrous composition comprising silver dihydrogen citrate and citric acid (wherein the composition comprises a molar excess of citric acid over silver dihydrogen citrate). Also disclosed is a process for making the above anhydrous composition which comprising the steps of: (a) providing a stock solution comprising an antimicrobial amount of silver dihydrogen citrate, citric acid and water; (b) freezing the stock solution to form a frozen solution; and (c) freeze-drying the frozen solution to form the anhydrous composition. A method to prepare a stable aqueous solution containing an antimicrobial amount of silver dihydrogen citrate is further disclosed, wherein the method comprises diluting the above anhydrous composition with an aqueous diluent (such as substantially pure water).
Patent NZ-546300-A (NZ)
Title: Immunogenic composition and method of developing a vaccine based on fusion protein
Inventor: KARP NELSON M
IPC: A61K39/02
Filed: 2004-10-25
Abstract: Provided is a composition including specified HIV-1 fusion protein nucleic acid sequences or portions thereof and a pharmaceutically acceptable support capable of eliciting a Th-1 immune response to HIV-1. Further provided is the use of the composition for the manufacture of a medicament for treating HIV and use of the composition to treat animals.
Patent NZ-546871-A (NZ)
Title: Mobile device dynamic update
Inventor: MCGOVERN MURRAY
Filed: 2006-05-01
Abstract: A remote mobile device application maintenance system is disclosed. An application server retains at least one application including an application version indicator. The application is operable on a remote device and the application server retains incremental updates to the application and has an uploading facility capable of uploading the application to a remote device and of uploading incremental updates to a remote device reporting the attempted viewing of a version of the application. A remote device has a user display and means for interaction with the display. The remote device is capable of retaining at least the application. A version detector operates in the remote device and detects the application version when the application is instantiated on the remote device. A version reporter in the mobile device reports the detected version to an application server when the viewer attempts to view the application interface. In an application updater in the remote device capable of receiving from the application server incremental updates to an application and updating the application before the application instantiation is completed.
Patent NZ-552809-A (NZ)
Title: Method for producing 4-(benzimidazolylmethylamino)-benzamides
Inventor: ZERBAN GEORG
IPC: C07D401/12
Filed: 2005-06-18
Abstract: Disclosed is a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, wherein (a) an optionally suitably substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) the product thus obtained is hydrogenated, and (c) optionally the amidino group is carbonylated.
Patent NZ-552911-A (NZ)
Title: Systems and methods of utilizing electrical readings in the determination of treatment
Inventor: HORNE DOUGLAS S
Filed: 2004-09-21
Abstract: A method for diagnosing aliments in humans based on electrical readings and for suggesting appropriate remedies based on the diagnosed aliments is disclosed. At least two electrical readings from acupuncture points on a human body are measured. The measuring each electrical reading comprises locating a dermal area of a patient proximate a meridian and contacting with a probe the dermal area. The probe comprises a stationary element to stabilize the probe against the dermal area; a probe tip operably connected to a biasing element to apply a pressure to the dermal area; a detector operably connected to the probe tip to detect an electrical signal corresponding to the pressure; a feedback loop connected to the detector to provide a feedback signal containing information with respect to the electrical signal; and a biasing element connected to the feedback loop to receive the feedback signal and adjust the pressure in accordance with the feedback signal. An electrical signal is obtained from the probe corresponding to the meridian. A present electrical signal value of the dermal area corresponding to a present amount of pressure is iteratively compared to a previous electrical signal value corresponding to a previous amount of pressure; and a future amount of pressure is changed when the present electrical signal value is substantially different than the previous electrical signal value. A diagnosis of a particular ailment is automatically generated by combining and compiling the at least two electrical readings through a correlation algorithm that correlates the at least two electrical readings with similar readings from a clinical information database containing electrical readings from a plurality of patients; and at least one known diagnosis for each of the plurality of patients. The at least one known diagnosis is associated with the electrical readings for that patient. Potential remedy information is determined by correlating the generated diagnosis to a set of known remedy information corresponding to the generated diagnosis.
Patent NZ-553587-A (NZ)
Title: Extended release tablet formulation containing pramipexole or a pharmacutically acceptable salt thereof
Inventor: FRIEDL THOMAS
IPC: A61K31/4745
Filed: 2005-07-25
Abstract: Disclosed is an extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix, the matrix comprising at least two water swelling polymers, wherein one of said polymers is pregelatinized starch, and wherein another one of said polymers is an anionic polymer, and wherein the extended release tablet formulation further comprises a water swelling polymer that is not pregelatinized starch or an anionic polymer.
Patent NZ-553669-A (NZ)
Title: C-aryl glucoside SGLT2 inhibitors and method for their production
Inventor: WASHBURN WILLIAM
IPC: A61K31/70
Filed: 2005-09-23
Abstract: Disclosed is a C-aryl glucoside as represented by formula I. Further disclosed is a pharmaceutical composition comprising the above compound and a pharmaceutically acceptable carrier therefor; or a pharmaceutical combination comprising the above compound and at least one therapeutic agent selected from the group consisting of antidiabetic agents (such as metformin, glyburide, glimepiride, glipyride, glipizide, chlorpropamide, gliclazide, acarbose, miglitol, pioglitazone, troglitazone, rosiglitazone, insulin, isaglitazone, repaglinide, nateglinide, muraglitizar or peliglitazar), anti-obesity agents (such as rimonabant, orlistat, sibutramine, topiramate, dexamphetamine, phentermine, phenylpropanolamine or mazindol), anti-hypertensive agents, anti-atherosclerotic agents or lipid-lowering agents (such as pravastatin, lovastatin, simvastatin, atorvastatin, cerivastatin, fluvastatin, nisvastatin, visastatin, atavastatin, rosuvastatin, fenofibrate, gernfibrozil, clofibrate or avasimibe).
Patent NZ-554723-A (NZ)
Title: Antisense oligonucleotides against CCR3 chemokine receptor
Inventor: ZEMZOUMI KHALID
IPC: C12N15/113
Filed: 2005-10-27
Abstract: Disclosed is an antisense oligonucleotide, wherein the oligonucleotide is one of (i) a sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 14 and (ii) a modified oligonucleotide of a sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 14 and capable of downregulating CCR3 chemokine receptor. The antisense oligonucleotides are for treating and/or preventing at least one of asthma, allergy, hypereosinophilia, general inflammation and cancer.
Patent NZ-556118-A (NZ)
Title: Inserter for a medical infuser
Inventor: MOGENSEN LASSE WESSELTOFT
IPC: A61M5/158
Filed: 2005-12-09
Abstract: An infuser for an angled infusion set comprises a set housing 1, a cannula housing 3, a needle hub 2, a spring and a carrier body 4 where the set housing 1 has internal guides 9a 9b 9c that interact with guides 9d 9e on the carrier body 4 to guide the movement of the carrier body 4. The cannula housing 3 contains a soft cannula 5 that is to be placed below the skin, and the needle hub 2 contains an insertion needle 6 for piercing the skin. The needle hub 2 and the carrier body 4 are permanently joined to each other. The cannula housing 3 and the needle hub 2 are releasably connected to each other and when they are connected the insertion needle 6 is at the end of the cannula 5. The spring is connected to a release button 7. When the button 7 is pressed, the spring forces the cannula housing 3, the needle hub 2 and the carrier body 4 to a forward position where the needle 6 and the cannula 5 can be placed intravenously. The lower part of the set housing 1 has two projections 10 that indicate the correct insertion angle of the needle 6 during insertion.